Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine spray to inhibit duodenal peristalsis during ERCP
jRCTs031190059Active, not recruiting
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in acute cholangitis, obstructive jaundice, pancreatic cancer (PC) and 1 more comparing Lidocaine spray with Placebo PG water spray (2 arms). Primary endpoint: Ceased peristalsis. Started Oct 2019; status: active, not recruiting.
02
Drugs
lidocaine
03
Conditions
acute cholangitisobstructive jaundicepancreatic cancer (PC)intraductal papillary mucinous neoplasm (IPMN)
Beyond the preview
Go deeper on jRCTs031190059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190059.